{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:56:54Z","timestamp":1759564614419},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is limited evidence, so far, as to the optimal management of women with a prior obstetric history of antepartum complications attributed to thrombosis. We aimed to investigate the contribution of close antepartum surveillance on pregnancy outcome among women with prior antepartum complications attributed to thrombosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study was conducted on all women who were delivered, conceived and delivered again between January 2000 and January 2006 at a university teaching hospital. Women included were managed in previous pregnancy at a low risk setting and had unpredicted antepartum complications occurring at a gestational age of 23 weeks or more. Antepartum complications considered were intrauterine fetal death, neonates who were small for gestational age, severe pre-eclampsia and placental abruption. All women were tested for the presence of thrombophilia after delivery. In the following pregnancy, only women found to have any thrombophilia (thrombophilic group) were treated with enoxaparin. Both the thrombophilic group and the non-thrombophilic group (tested negatively for thrombophilia) were managed and observed closely at our high-risk pregnancy clinic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ninety-seven women, who conceived at least once after the diagnosis of the relevant antepartum complications, were included in this study. Forty-nine had any thrombophilia and 48 tested negatively. Composite antepartum complications (all antepartum complications considered) were reduced significantly after close antepartum surveillance in both groups. Mean birth weight and mean gestational age improved significantly and were comparable between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Close antepartum surveillance may contribute to improvement in the perinatal outcomes of women with prior antepartum complications attributed to thrombosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7827-6-55","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T07:14:54Z","timestamp":1229411694000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of close surveillance on pregnancy outcome among women with a prior history of antepartum complications attributed to thrombosis: a cohort study"],"prefix":"10.1186","volume":"6","author":[{"given":"Raed","family":"Salim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tali","family":"Czarnowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Nachum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,21]]},"reference":[{"key":"461_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/j.semperi.2007.05.002","volume":"31","author":"N Hossain","year":"2007","unstructured":"Hossain N, Paidas MJ: Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies. Semin Perinatol. 2007, 31: 208-212. 10.1053\/j.semperi.2007.05.002.","journal-title":"Semin Perinatol"},{"key":"461_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1521-6926(02)00099-3","volume":"16","author":"JS Younis","year":"2003","unstructured":"Younis JS, Samueloff A: Gestational vascular complications. Best Pract Res Clin Haematol. 2003, 16: 135-151. 10.1016\/S1521-6926(02)00099-3.","journal-title":"Best Pract Res Clin Haematol"},{"key":"461_CR3","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","volume":"15","author":"HA Mousa","year":"2000","unstructured":"Mousa HA, Alfirevic1 Z: Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod. 2000, 15: 1830-1833. 10.1093\/humrep\/15.8.1830.","journal-title":"Hum Reprod"},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1471-0528.2004.00182.x","volume":"111","author":"Z Weiner","year":"2004","unstructured":"Weiner Z, Beck-Fruchter R, Weiss A, Hujirat Y, Shalev E, Shalev SA: Thrombophilia and stillbirth: possible connection by intrauterine growth restriction. BJOG. 2004, 111: 780-783. 10.1111\/j.1471-0528.2004.00182.x.","journal-title":"BJOG"},{"key":"461_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","volume":"348","author":"FE Preston","year":"1996","unstructured":"Preston FE, Rosendaal FR, Walker ID: Increased fetal loss in women with heritable thrombophilia. Lancet. 1996, 348: 913-916. 10.1016\/S0140-6736(96)04125-6.","journal-title":"Lancet"},{"key":"461_CR6","first-page":"729","volume":"88","author":"A Many","year":"2003","unstructured":"Many A, Kupferminc MJ: Thrombophilia and adverse pregnancy outcome. Hematologica. 2003, 88: 729-731.","journal-title":"Hematologica"},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/s-2003-38834","volume":"29","author":"MJ Kupferminc","year":"2003","unstructured":"Kupferminc MJ, Eldor A: Inherited thrombophilia and gestational vascular complications. Semin Thromb Hemost. 2003, 29: 185-194. 10.1055\/s-2003-38834.","journal-title":"Semin Thromb Hemost"},{"key":"461_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","volume":"179","author":"Z Wiener-Megnagi","year":"1998","unstructured":"Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E: Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol. 1998, 179: 1565-1567. 10.1016\/S0002-9378(98)70025-0.","journal-title":"Am J Obstet Gynecol"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","volume":"348","author":"FE Preston","year":"1996","unstructured":"Preston FE, Rosendaal FR, Walker ID, Bri\u00ebt E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, Meer van der FJ: Increased fetal loss in women with heritable thrombophilia. Lancet. 1996, 348: 913-916. 10.1016\/S0140-6736(96)04125-6.","journal-title":"Lancet"},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1521-6934(03)00006-3","volume":"17","author":"B Brenner","year":"2003","unstructured":"Brenner B, Kupferminc MJ: Inherited thrombophilia and poor pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2003, 17: 427-439. 10.1016\/S1521-6934(03)00006-3.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"461_CR11","first-page":"416","volume":"5","author":"J Zlotogora","year":"2003","unstructured":"Zlotogora J, Leventhal A, Amitai Y: The impact of congenital malformations and Mendelian diseases on infant mortality in Israel. IMAJ. 2003, 5: 416-418.","journal-title":"IMAJ"},{"key":"461_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/03014460110100928","volume":"29","author":"R Vardi-Saliternik","year":"2002","unstructured":"Vardi-Saliternik R, Friedlander Y, Cohen T: Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol. 2002, 29: 422-431. 10.1080\/03014460110100928.","journal-title":"Ann Hum Biol"},{"key":"461_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","volume":"80","author":"N Riyazi","year":"1998","unstructured":"Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA: Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Reprod Biol. 1998, 80: 49-54. 10.1016\/S0301-2115(98)00083-9.","journal-title":"Eur J Obstet Reprod Biol"},{"key":"461_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","volume":"77","author":"BJ Hunt","year":"1997","unstructured":"Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N, Hughes G, Khamashta M: Thromboprophylaxis with low molecular weight heparin (Fragmin) in high-risk pregnancies. Thromb Haemost. 1997, 77: 39-41.","journal-title":"Thromb Haemost"},{"key":"461_CR15","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","volume":"103","author":"JC Gris","year":"2004","unstructured":"Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Mar\u00e8s P: Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004, 103: 3695-3699. 10.1182\/blood-2003-12-4250.","journal-title":"Blood"},{"key":"461_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","volume":"314","author":"R Rai","year":"1997","unstructured":"Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997, 314: 253-257.","journal-title":"BMJ"},{"key":"461_CR17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996, 174: 1584-1589. 10.1016\/S0002-9378(96)70610-5.","journal-title":"Am J Obstet Gynecol"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","volume":"100","author":"RG Farquharson","year":"2002","unstructured":"Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002, 100: 408-413. 10.1016\/S0029-7844(02)02165-8.","journal-title":"Obstet Gynecol"},{"key":"461_CR19","first-page":"83","volume":"62","author":"JJ Kalk","year":"2004","unstructured":"Kalk JJ, Huisjes AJ, de Groot CJ, van Beek E, van Pampus MG, Spaanderman ME, van Eyck J, Oei SG, Bezemer PD, de Vries JI: Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?. Neth J Med. 2004, 62: 83-87.","journal-title":"Neth J Med"},{"key":"461_CR20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1538-7836.2005.01417.x","volume":"3","author":"I Pabinger","year":"2005","unstructured":"Pabinger I, Vormittag R: Thrombophilia and pregnancy outcomes. J Thromb Haemost. 2005, 3: 1603-1610. 10.1111\/j.1538-7836.2005.01417.x.","journal-title":"J Thromb Haemost"},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0015-0282(99)00360-X","volume":"72","author":"Z Blumenfeld","year":"1999","unstructured":"Blumenfeld Z, Brenner B: Thrombophilia-associated pregnancy wastage. Fertil Steril. 1999, 72: 765-774. 10.1016\/S0015-0282(99)00360-X.","journal-title":"Fertil Steril"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1600-0897.2008.00640.x","volume":"60","author":"CB Coulam","year":"2008","unstructured":"Coulam CB, Wallis D, Weinstein J, Dasgupta DS, Jeyendran RS: Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol. 2008, 60: 426-431. 10.1111\/j.1600-0897.2008.00640.x.","journal-title":"Am J Reprod Immunol"},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1515\/CCLM.2001.126","volume":"39","author":"WL Nelen","year":"2001","unstructured":"Nelen WL: Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med. 2001, 39: 758-763. 10.1515\/CCLM.2001.126.","journal-title":"Clin Chem Lab Med"},{"key":"461_CR24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH03-09-0554","volume":"91","author":"A Dossenbach-Glaninger","year":"2004","unstructured":"Dossenbach-Glaninger A, van Trotsenburg M, Krugluger W, Dossenbach MR, Oberkanins C, Huber J, Hopmeier P: Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss. Thromb Haemost. 2004, 91: 694-699.","journal-title":"Thromb Haemost"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0049-3848(02)00181-0","volume":"106","author":"B Kemkes-Matthes","year":"2002","unstructured":"Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorff A, Matthes KJ: Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res. 2002, 106: 183-185. 10.1016\/S0049-3848(02)00181-0.","journal-title":"Thromb Res"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-6-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:05:53Z","timestamp":1630458353000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-6-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-6-55","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,21]]},"assertion":[{"value":"6 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"55"}}